Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies

Bibliography

• Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007;64(5):543-52
   PubMed Web of Science ®Google Scholar
• Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011;68(3):241-51
   PubMed Web of Science ®Google Scholar
• Dilsaver SC. An estimate of the minimum economic burden of bipolar I and II disorders in the United States: 2009. J Affect Disord 2011;129(1-3):79-83
   PubMed Web of Science ®Google Scholar
• Perlis RH, Ostacher MJ, Patel JK, et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006;163(2):217-24
   PubMed Web of Science ®Google Scholar
• Ghanizadeh A, Akhondzadeh S, Hormozi M, et al. Glutathione-related factors and oxidative stress in autism, a review. Curr Med Chem 2012;19(23):4000-5
   PubMedGoogle Scholar
• Selhub J, Miller JW. The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1992;55(1):131-8
   PubMed Web of Science ®Google Scholar
• Hu CY, Qian ZZ, Gong FF, et al. Methylenetetrahydrofolate reductase (MTHFR) polymorphism susceptibility to schizophrenia and bipolar disorder: an updated meta-analysis. J Neural Transm 2015;122(2):307-20
   PubMedGoogle Scholar
• Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10(1):111-13
   PubMed Web of Science ®Google Scholar
• Peerbooms OL, van Os J, Drukker M, et al. Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability? Brain Behav Immun 2011;25(8):1530-43
   PubMed Web of Science ®Google Scholar
• Boldyrev AA. Molecular mechanisms of homocysteine toxicity. Biochemistry (Mosc) 2009;74(6):589-98
   PubMed Web of Science ®Google Scholar
• Nabi H, Bochud M, Glaus J, et al. Association of serum homocysteine with major depressive disorder: results from a large population-based study. Psychoneuroendocrinology 2013;38(10):2309-18
   PubMed Web of Science ®Google Scholar
• Folstein M, Liu T, Peter I, et al. The homocysteine hypothesis of depression. Am J Psychiatry 2007;164(6):861-7
   PubMed Web of Science ®Google Scholar
• Dietrich-Muszalska A, Malinowska J, Olas B, et al. The oxidative stress may be induced by the elevated homocysteine in schizophrenic patients. Neurochem Res 2012;37(5):1057-62
   PubMed Web of Science ®Google Scholar
• Ghanizadeh A. Increased glutamate and homocysteine and decreased glutamine levels in autism: a review and strategies for future studies of amino acids in autism. Dis Markers 2013;35(5):281-6
   PubMed Web of Science ®Google Scholar
• Gabryelewicz T, Styczynska M, Luczywek E, et al. The rate of conversion of mild cognitive impairment to dementia: predictive role of depression. Int J Geriatr Psychiatry 2007;22(6):563-7
   PubMed Web of Science ®Google Scholar
• Permoda-Osip A, Dorszewska J, Bartkowska-Sniatkowska A, et al. Vitamin B12 level may be related to the efficacy of single ketamine infusion in bipolar depression. Pharmacopsychiatry 2013;46(6):227-8
   PubMedGoogle Scholar
• Almeida OP, Flicker L, Yeap BB, et al. Aspirin decreases the risk of depression in older men with high plasma homocysteine. Transl Psychiatry 2012;2:e151
   PubMedGoogle Scholar
• Ozbek Z, Kucukali CI, Ozkok E, et al. Effect of the methylenetetrahydrofolate reductase gene polymorphisms on homocysteine, folate and vitamin B12 in patients with bipolar disorder and relatives. Prog Neuropsychopharmacol Biol Psychiatry 2008;32(5):1331-7
   PubMedGoogle Scholar
• Hirschfeld RM. History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry 2000;61(Suppl 6):4-6
   PubMed Web of Science ®Google Scholar
• Stahl SM. Novel therapeutics for depression: L-methylfolate as a trimonoamine modulator and antidepressant-augmenting agent. CNS Spectr 2007;12(10):739-44
   PubMed Web of Science ®Google Scholar
• Abdolmaleky HM, Smith CL, Faraone SV, et al. Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation. Am J Med Genet B Neuropsychiatr Genet 2004;127B(1):51-9
   PubMed Web of Science ®Google Scholar
• Gortz P, Hoinkes A, Fleischer W, et al. Implications for hyperhomocysteinemia: not homocysteine but its oxidized forms strongly inhibit neuronal network activity. J Neurol Sci 2004;218(1-2):109-14
   PubMedGoogle Scholar
• Kruman II, Culmsee C, Chan SL, et al. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 2000;20(18):6920-6
   PubMedGoogle Scholar
• de Sousa RT, Machado-Vieira R, Zarate CAJr, Manji HK. Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder. Expert Opin Ther Targets 2014;18(10):1131-47
   PubMed Web of Science ®Google Scholar
• Ghanizadeh A, Berk M. Molecular hydrogen: an overview of its neurobiological effects and therapeutic potential for bipolar disorder and schizophrenia. Med Gas Res 2013;3(1):11
   PubMedGoogle Scholar
• Berk M, Williams LJ, Jacka FN, et al. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med 2013;11:200
   PubMed Web of Science ®Google Scholar
• Moylan S, Maes M, Wray NR, Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry 2013;18(5):595-606
   PubMed Web of Science ®Google Scholar
• de Sousa RT, Zarate CAJr, Zanetti MV, et al. Oxidative stress in early stage Bipolar Disorder and the association with response to lithium. J Psychiatr Res 2014;50:36-41
   PubMed Web of Science ®Google Scholar
• Berk M, Berk L, Dodd S, et al. Stage managing bipolar disorder. Bipolar Disord 2014;16(5):471-7
   PubMedGoogle Scholar
• Ueland PM. Choline and betaine in health and disease. J Inherit Metab Dis 2011;34(1):3-15
   PubMed Web of Science ®Google Scholar
• Tsai JC, Perrella MA, Yoshizumi M, et al. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 1994;91(14):6369-73
   PubMed Web of Science ®Google Scholar
• Carpenter LL, Gawuga CE, Tyrka AR, et al. Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacology 2010;35(13):2617-23
   PubMed Web of Science ®Google Scholar
• Aschbacher K, O’Donovan A, Wolkowitz OM, et al. Good stress, bad stress and oxidative stress: insights from anticipatory cortisol reactivity. Psychoneuroendocrinology 2013;38(9):1698-708
   PubMed Web of Science ®Google Scholar
• Smolin LA, Benevenga NJ, Berlow S. The use of betaine for the treatment of homocystinuria. J Pediatr 1981;99(3):467-72
   PubMed Web of Science ®Google Scholar
• Fries GR, Pfaffenseller B, Stertz L, et al. Staging and neuroprogression in bipolar disorder. Curr Psychiatry Rep 2012;14(6):667-75
   PubMedGoogle Scholar
• Susser E, Brown AS, Klonowski E, et al. Schizophrenia and impaired homocysteine metabolism: a possible association. Biol Psychiatry 1998;44(2):141-3
   PubMedGoogle Scholar
• Williams LJ, Bjerkeset O, Langhammer A, et al. The association between depressive and anxiety symptoms and bone mineral density in the general population: the HUNT Study. J Affect Disord 2011;131(1-3):164-71
   PubMedGoogle Scholar
• Wang Y, Liu X, Zhang D, et al. The effects of apoptosis vulnerability markers on the myocardium in depression after myocardial infarction. BMC Med 2013;11:32
   PubMed Web of Science ®Google Scholar
• O’Neil A, Williams ED, Stevenson CE, et al. Co-morbid cardiovascular disease and depression: sequence of disease onset is linked to mental but not physical self-rated health. Results from a cross-sectional, population-based study. Soc Psychiatry Psychiatr Epidemiol 2012;47(7):1145-51
   PubMedGoogle Scholar
• Yirmiya R, Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 2011;25(2):181-213
   PubMed Web of Science ®Google Scholar
• Slopen N, Kubzansky LD, McLaughlin KA, Koenen KC. Childhood adversity and inflammatory processes in youth: a prospective study. Psychoneuroendocrinology 2013;38(2):188-200
   PubMed Web of Science ®Google Scholar
• Gabbay V, Klein RG, Alonso CM, et al. Immune system dysregulation in adolescent major depressive disorder. J Affect Disord 2009;115(1-2):177-82
   PubMedGoogle Scholar
• Kauer-Sant’Anna M, Kapczinski F, Andreazza AC, et al. Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol 2009;12(4):447-58
   PubMed Web of Science ®Google Scholar
• Maes M, Berk M, Goehler L, et al. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med 2012;10:66
   PubMed Web of Science ®Google Scholar
• Steiner J, Walter M, Gos T, et al. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J Neuroinflammation 2011;8:94
   PubMed Web of Science ®Google Scholar
• Duman RS, Aghajanian GK. Synaptic dysfunction in depression: potential therapeutic targets. Science 2012;338(6103):68-72
   PubMed Web of Science ®Google Scholar
• Anda RF, Butchart A, Felitti VJ, Brown DW. Building a framework for global surveillance of the public health implications of adverse childhood experiences. Am J Prev Med 2010;39(1):93-8
   PubMed Web of Science ®Google Scholar
• Padmos RC, Van Baal GC, Vonk R, et al. Genetic and environmental influences on pro-inflammatory monocytes in bipolar disorder: a twin study. Arch Gen Psychiatry 2009;66(9):957-65
   PubMed Web of Science ®Google Scholar
• Delport D, Schoeman R, van der Merwe N, et al. Significance of dietary folate intake, homocysteine levels and MTHFR 677 C>T genotyping in South African patients diagnosed with depression: test development for clinical application. Metab Brain Dis 2014;29(2):377-84
   PubMed Web of Science ®Google Scholar
• Forti P, Rietti E, Pisacane N, et al. Blood homocysteine and risk of depression in the elderly. Arch Gerontol Geriatr 2010;51(1):21-5
   PubMedGoogle Scholar
• Almeida OP, McCaul K, Hankey GJ, et al. Homocysteine and depression in later life. Arch Gen Psychiatry 2008;65(11):1286-94
   PubMed Web of Science ®Google Scholar
• Ford AH, Flicker L, Singh U, et al. Homocysteine, depression and cognitive function in older adults. J Affect Disord 2013;151(2):646-51
   PubMed Web of Science ®Google Scholar
• Ebesunun MO, Eruvulobi HU, Olagunju T, Owoeye OA. Elevated plasma homocysteine in association with decreased vitamin B(12), folate, serotonin, lipids and lipoproteins in depressed patients. Afr J Psychiatry (Johannesbg) 2012;15(1):25-9
   PubMedGoogle Scholar
• Osher Y, Bersudsky Y, Silver H, et al. Neuropsychological correlates of homocysteine levels in euthymic bipolar patients. J Affect Disord 2008;105(1-3):229-33
   PubMedGoogle Scholar
• Osher Y, Sela BA, Levine J, Belmaker RH. Elevated homocysteine levels in euthymic bipolar disorder patients showing functional deterioration. Bipolar Disord 2004;6(1):82-6
   PubMedGoogle Scholar
• Levine J, Sela BA, Osher Y, Belmaker RH. High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model. Prog Neuropsychopharmacol Biol Psychiatry 2005;29(7):1181-91
   PubMedGoogle Scholar
• Ezzaher A, Mouhamed DH, Mechri A, et al. Hyperhomocysteinemia in Tunisian bipolar I patients. Psychiatry Clin Neurosci 2011;65(7):664-71
   PubMed Web of Science ®Google Scholar
• Bromberg A, Bersudsky Y, Levine J, Agam G. Global leukocyte DNA methylation is not altered in euthymic bipolar patients. J Affect Disord 2009;118(1-3):234-9
   PubMed Web of Science ®Google Scholar
• Chiarani F, Tramontina JF, Ceresér KM, et al. Homocysteine and other markers of cardiovascular risk during a manic episode in patients with bipolar disorder. Rev Bras Psiquiatr 2013;35(2):157-60
   PubMedGoogle Scholar
• Dias VV, Brissos S, Cardoso C, et al. Serum homocysteine levels and cognitive functioning in euthymic bipolar patients. J Affect Disord 2009;113(3):285-90
   PubMedGoogle Scholar
• Doganavsargil Baysal GO, Gökmen Z, Akbaş H, et al. [Association of serum homocysteine and methionine levels with cognition and functioning in bipolar disorder]. Turk Psikiyatri Derg 2013;24(1):7-16
   PubMedGoogle Scholar
• Davis J, Maes M, Andreazza A, et al. Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compass. Mol Psychiatry 2014. [Epub ahead of print]
   Google Scholar
• Dittmann S, Seemüller F, Schwarz MJ, et al. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results. Bipolar Disord 2007;9(1-2):63-70
   PubMedGoogle Scholar
• Taylor MJ, Carney SM, Goodwin GM, Geddes JR. Folate for depressive disorders: systematic review and meta-analysis of randomized controlled trials. J Psychopharmacol 2004;18(2):251-6
   PubMed Web of Science ®Google Scholar
• Bedson E, Bell D, Carr D, et al. Folate augmentation of treatment – evaluation for depression (FolATED): randomised trial and economic evaluation. Health Technol Assess 2014;18(48):vii-viii; 1-159
   PubMed Web of Science ®Google Scholar
• Behzadi AH, Omrani Z, Chalian M, et al. Folic acid efficacy as an alternative drug added to sodium valproate in the treatment of acute phase of mania in bipolar disorder: a double-blind randomized controlled trial. Acta Psychiatr Scand 2009;120(6):441-5
   PubMedGoogle Scholar
• Raison CL, Rutherford RE, Woolwine BJ, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 2013;70(1):31-41
   PubMed Web of Science ®Google Scholar
• Goyette P, Sumner JS, Milos R, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nat Genet 1994;7(4):551
   PubMed Web of Science ®Google Scholar
• Karagiannis TC, Maulik N. Factors influencing epigenetic mechanisms and related diseases. Antioxid Redox Signal 2012;17(2):192-4
   PubMedGoogle Scholar
• Kinoshita M, Numata S, Tajima A, et al. DNA methylation signatures of peripheral leukocytes in schizophrenia. Neuromolecular Med 2013;15(1):95-101
   PubMed Web of Science ®Google Scholar
• Gilbody S, Lewis S, Lightfoot T. Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol 2007;165(1):1-13
   PubMed Web of Science ®Google Scholar
• Cohen-Woods S, Craig I, Gaysina D, et al. The bipolar association case-control study (BACCS) and meta-analysis: no association with the 5,10-Methylenetetrahydrofolate reductase gene and bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 2010;153B(7):1298-304
   PubMedGoogle Scholar
• Zintzaras E, Ziogas DC, Kitsios GD, et al. MTHFR gene polymorphisms and response to chemotherapy in colorectal cancer: a meta-analysis. Pharmacogenomics 2009;10(8):1285-94
   PubMed Web of Science ®Google Scholar
• Permoda-Osip A, Dmitrzak-Weglarz M, Hauser J, Rybakowski JK. Are genes connected with homocysteine metabolism associated with bipolar disorder? Neuropsychobiology 2014;69(2):107-11
   PubMedGoogle Scholar
• Sibani S, Christensen B, O’Ferrall E, et al. Characterization of six novel mutations in the methylenetetrahydrofolate reductase (MTHFR) gene in patients with homocystinuria. Hum Mutat 2000;15(3):280-7
   PubMed Web of Science ®Google Scholar
• Kempisty B, Bober A, Łuczak M, et al. Distribution of 1298A>C polymorphism of methylenetetrahydrofolate reductase gene in patients with bipolar disorder and schizophrenia. Eur Psychiatry 2007;22(1):39-43
   PubMedGoogle Scholar
• Singh AB, Bousman CA, Ng C, Berk M. Antidepressant pharmacogenetics. Curr Opin Psychiatry 2014;27(1):43-51
   PubMed Web of Science ®Google Scholar
• Dong E, Chen Y, Gavin DP, et al. Valproate induces DNA demethylation in nuclear extracts from adult mouse brain. Epigenetics 2010;5(8):730-5
   PubMed Web of Science ®Google Scholar
• Gorjipour F, Asadi Y, K Osguei N, et al. Serum level of homocysteine, folate and vitamin-B12 in epileptic patients under carbamazepine and sodium valproate treatment: a systematic review and meta-analysis. Iran Red Crescent Med J 2013;15(3):249-53
   PubMed Web of Science ®Google Scholar
• Iglesias-Gutierrez E, Egan B, Díaz-Martínez ÁE, et al. Transient increase in homocysteine but not hyperhomocysteinemia during acute exercise at different intensities in sedentary individuals. PLoS One 2012;7(12):e51185
   PubMed Web of Science ®Google Scholar
• Hayashino Y, Jackson J, Hirata T, et al. Effects of exercise on C-reactive protein, inflammatory cytokine and adipokine in patients with type 2 diabetes: a meta-analysis of randomized controlled trials. Metabolism 2014;63(3):431-40
   PubMed Web of Science ®Google Scholar
• Stahl Z, Belmaker RH, Friger M, Levine J. Nutritional and life style determinants of plasma homocysteine in schizophrenia patients. Eur Neuropsychopharmacol 2005;15(3):291-5
   PubMedGoogle Scholar
• Esfahani A, Wong JM, Truan J, et al. Health effects of mixed fruit and vegetable concentrates: a systematic review of the clinical interventions. J Am Coll Nutr 2011;30(5):285-94
   PubMed Web of Science ®Google Scholar
• Xiao Y, Zhang Y, Wang M, et al. Dietary protein and plasma total homocysteine, cysteine concentrations in coronary angiographic subjects. Nutr J 2013;12(1):144
   PubMedGoogle Scholar
• Cao L, Lou X, Zou Z, et al. Folic acid attenuates hyperhomocysteinemia-induced glomerular damage in rats. Microvasc Res 2013;89:146-52
   PubMed Web of Science ®Google Scholar
• Jacka FN, Maes M, Pasco JA, et al. Nutrient intakes and the common mental disorders in women. J Affect Disord 2012;141(1):79-85
   PubMedGoogle Scholar
• Bamashmoos SA, Al-Nuzaily MA, Al-Meeri AM, Ali FH. Relationship between total homocysteine, total cholesterol and creatinine levels in overt hypothyroid patients. Springerplus 2013;2:423
   PubMedGoogle Scholar
• Campesi I, Carru C, Zinellu A, et al. Regular cigarette smoking influences the transsulfuration pathway, endothelial function, and inflammation biomarkers in a sex-gender specific manner in healthy young humans. Am J Transl Res 2013;5(5):497-509
   PubMedGoogle Scholar
• Park SB, Georgiades A. Changes in body composition predict homocysteine changes and hyperhomocysteinemia in Korea. J Korean Med Sci 2013;28(7):1015-20
   PubMed Web of Science ®Google Scholar
• Dittmann S, Seemüller F, Grunze HC, et al. The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study. J Clin Psychiatry 2008;69(6):899-906
   PubMedGoogle Scholar
• Permoda-Osip A, Dorszewska J, Skibinska M, et al. Hyperhomocysteinemia in bipolar depression: clinical and biochemical correlates. Neuropsychobiology 2013;68(4):193-6
   PubMed Web of Science ®Google Scholar
• Vuksan-Cusa B, Sagud M, Jakovljevic M, et al. Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia. Nord J Psychiatry 2012;67(5):320-5
   PubMedGoogle Scholar
• Vuksan-Cusa B, Jakovljević M, Sagud M, et al. Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics. Psychiatry Res 2011;189(1):21-5
   PubMedGoogle Scholar